Cargando…

Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus

To date, all major modes of monoclonal antibody therapy targeting SARS-CoV-2 have lost significant efficacy against the latest circulating variants. As SARS-CoV-2 omicron sublineages account for over 90% of COVID-19 infections, evasion of immune responses generated by vaccination or exposure to prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ketaren, Natalia E., Mast, Fred D., Fridy, Peter C., Paul Olivier, Jean, Sanyal, Tanmoy, Sali, Andrej, Chait, Brian T., Rout, Michael P., Aitchison, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369967/ https://www.ncbi.nlm.nih.gov/pubmed/37503298 http://dx.doi.org/10.1101/2023.07.14.549041

Ejemplares similares

Abstract 2702: Highly synergistic combinations of nanobodies that target SARS-CoV-2 reduce viral load in hACE2 transgenic mice
por: Olivier, Paul, et al.
Publicado: (2023)

Expanding and improving nanobody repertoires using a yeast display method: Targeting SARS-CoV-2
por: Cross, Frederick R., et al.
Publicado: (2023)

Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
por: Mast, Fred D., et al.
Publicado: (2021)

A robust pipeline for rapid production of versatile nanobody repertoires
por: Fridy, Peter C., et al.
Publicado: (2014)

Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
por: Mast, Fred D, et al.
Publicado: (2021)

Screening, Expression, and Identification of Nanobody against SARS-CoV-2 Spike Protein
por: Su, Qianling, et al.
Publicado: (2022)

Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2
por: Tang, Qilong, et al.
Publicado: (2021)

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
por: Tong, Pei, et al.
Publicado: (2021)

Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
por: Tong, Pei, et al.
Publicado: (2021)

Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
por: Mast, Fred D., et al.
Publicado: (2020)

Inhaled nanobodies against COVID-19
por: Martinez-Delgado, Gustavo
Publicado: (2020)

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
por: Starr, Tyler N., et al.
Publicado: (2022)

A framework for studying behavioral evolution by reconstructing ancestral repertoires
por: Hernández, Damián G, et al.
Publicado: (2021)

Identification and characterization of blocking nanobodies against human CD70: Identification and characterization of blocking nanobodies
por: Zhang, Xin, et al.
Publicado: (2022)

The innate immune repertoire in Cnidaria - ancestral complexity and stochastic gene loss
por: Miller, David J, et al.
Publicado: (2007)

Components of Coated Vesicles and Nuclear Pore Complexes Share a Common Molecular Architecture
por: Devos, Damien, et al.
Publicado: (2004)

Correction: Components of Coated Vesicles and Nuclear Pore Complexes Share a Common Molecular Architecture
por: Devos, Damien, et al.
Publicado: (2005)

Pinopsin evolved as the ancestral dim-light visual opsin in vertebrates
por: Sato, Keita, et al.
Publicado: (2018)

Prospects of Neutralizing Nanobodies Against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2021)

Generation and Characterization of a Nanobody Against SARS-CoV
por: Li, Jiang-Fan, et al.
Publicado: (2021)

Characterization of rabbit polyclonal antibody against camel recombinant nanobodies
por: Khalaf, Houssam-Eddin, et al.
Publicado: (2022)

Nanobodies against Pfs230 block Plasmodium falciparum transmission
por: Dietrich, Melanie H., et al.
Publicado: (2022)

Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
por: Yuki, Yoshikazu, et al.
Publicado: (2022)

Activity of ancestral restriction factors against ancient retroviruses
por: Rahm, Nadia, et al.
Publicado: (2009)

Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library
por: Yan, Junrong, et al.
Publicado: (2015)

Applications of nanobodies in the prevention, detection, and treatment of the evolving SARS-CoV-2
por: Wang, Wenyi, et al.
Publicado: (2023)

Polyphenism of a Novel Trait Integrated Rapidly Evolving Genes into Ancestrally Plastic Networks
por: Casasa, Sofia, et al.
Publicado: (2020)

Interactome Mapping Reveals the Evolutionary History of the Nuclear Pore Complex
por: Obado, Samson O., et al.
Publicado: (2016)

Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
por: Romão, Ema, et al.
Publicado: (2020)

Preparation and Characterization of Anti-GPC3 Nanobody Against Hepatocellular Carcinoma
por: Xia, Lijie, et al.
Publicado: (2020)

A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis
por: Karami, Elmira, et al.
Publicado: (2020)

Creating a Selective Nanobody Against 3-Nitrotyrosine Containing Proteins
por: Van Fossen, Elise M., et al.
Publicado: (2022)

Multifaceted Activities of Seven Nanobodies against Complement C4b
por: De la O Becerra, Karla I., et al.
Publicado: (2022)

Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021)

Identification and Characterization of Specific Nanobodies against Trop-2 for Tumor Targeting
por: Hu, Yaozhong, et al.
Publicado: (2022)

Antibody–nanobody combination increases their neutralizing activity against SARS-CoV-2 and nanobody H11-H4 is effective against Alpha, Kappa and Delta variants
por: Nguyen, Hung, et al.
Publicado: (2022)

Repertoires of Spike Avalanches Are Modulated by Behavior and Novelty
por: Ribeiro, Tiago L., et al.
Publicado: (2016)

The Yeast Nuclear Pore Complex: Composition, Architecture, and Transport Mechanism
por: Rout, Michael P., et al.
Publicado: (2000)

The slow-evolving Acorus tatarinowii genome sheds light on ancestral monocot evolution
por: Shi, Tao, et al.
Publicado: (2022)

Lineage-specific proteins essential for endocytosis in trypanosomes
por: Manna, Paul T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7qjvbelccsflecnidecv0uthjl